The award is part of a Long-Term Agreement under which the company will supply bOPV in 10 and 20-vial presentations to UNICEF from April 1, 2026, to March 31, 2030. Shares of Panacea Biotec Ltd ended at ₹415.00, up by ₹12.85, or 3.20%, on the BSE.
The award is part of a Long-Term Agreement under which the company will supply bOPV in 10 and 20-vial presentations to UNICEF from April 1, 2026, to March 31, 2030. Shares of Panacea Biotec Ltd ended at ₹415.00, up by ₹12.85, or 3.20%, on the BSE.